Genomic biomarkers play a crucial role in the personalized treatment of cancer. They allow for the identification of specific cancer types and subtypes, enabling targeted therapies that are more effective and have fewer side effects. For example, the identification of the HER2 gene amplification in breast cancer has led to the development of targeted therapies like trastuzumab.
